Annual Total Liabilities
$90.68 M
-$67.16 M-42.55%
December 31, 2024
Summary
- As of March 14, 2025, SYRE annual total liabilities is $90.68 million, with the most recent change of -$67.16 million (-42.55%) on December 31, 2024.
- During the last 3 years, SYRE annual total liabilities has risen by +$64.69 million (+248.97%).
- SYRE annual total liabilities is now -42.55% below its all-time high of $157.84 million, reached on December 31, 2023.
Performance
SYRE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$90.68 M
-$3.02 M-3.22%
December 31, 2024
Summary
- As of March 14, 2025, SYRE quarterly total liabilities is $90.68 million, with the most recent change of -$3.02 million (-3.22%) on December 31, 2024.
- Over the past year, SYRE quarterly total liabilities has dropped by -$67.16 million (-42.55%).
- SYRE quarterly total liabilities is now -79.97% below its all-time high of $452.67 million, reached on September 30, 2023.
Performance
SYRE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SYRE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.5% | -42.5% |
| 3 y3 years | +249.0% | +277.7% |
| 5 y5 years | +292.5% | +277.7% |
SYRE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | +335.1% | -80.0% | +382.3% |
| 5 y | 5-year | -42.5% | +335.1% | -80.0% | +382.3% |
| alltime | all time | -42.5% | +8470.9% | -80.0% | +8470.9% |
Spyre Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $90.68 M(-42.6%) | $90.68 M(-3.2%) |
| Sep 2024 | - | $93.70 M(+51.9%) |
| Jun 2024 | - | $61.68 M(-81.6%) |
| Mar 2024 | - | $335.33 M(+112.4%) |
| Dec 2023 | $157.84 M(+657.4%) | $157.84 M(-65.1%) |
| Sep 2023 | - | $452.67 M(+0.4%) |
| Jun 2023 | - | $450.90 M(+2298.3%) |
| Mar 2023 | - | $18.80 M(-9.8%) |
| Dec 2022 | $20.84 M(-19.8%) | - |
| Dec 2022 | - | $20.84 M(-13.2%) |
| Sep 2022 | - | $24.01 M(+6.5%) |
| Jun 2022 | - | $22.55 M(+4.8%) |
| Mar 2022 | - | $21.51 M(-17.2%) |
| Dec 2021 | $25.98 M(+19.3%) | $25.98 M(-3.7%) |
| Sep 2021 | - | $26.98 M(-3.5%) |
| Jun 2021 | - | $27.96 M(-29.9%) |
| Mar 2021 | - | $39.86 M(+83.0%) |
| Dec 2020 | $21.79 M(-5.7%) | $21.79 M(+12.5%) |
| Sep 2020 | - | $19.36 M(-6.3%) |
| Jun 2020 | - | $20.65 M(-6.0%) |
| Mar 2020 | - | $21.98 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $23.10 M(+124.1%) | $23.10 M(+13.8%) |
| Sep 2019 | - | $20.30 M(+13.5%) |
| Jun 2019 | - | $17.88 M(+46.2%) |
| Mar 2019 | - | $12.23 M(+18.6%) |
| Dec 2018 | $10.31 M(+79.6%) | $10.31 M(+35.7%) |
| Sep 2018 | - | $7.60 M(+21.2%) |
| Jun 2018 | - | $6.27 M(+6.8%) |
| Mar 2018 | - | $5.87 M(+2.2%) |
| Dec 2017 | $5.74 M(+40.1%) | $5.74 M(+14.9%) |
| Sep 2017 | - | $4.99 M(+10.0%) |
| Jun 2017 | - | $4.54 M(+11.2%) |
| Mar 2017 | - | $4.08 M(-0.3%) |
| Dec 2016 | $4.10 M(+60.7%) | $4.10 M(+6.1%) |
| Sep 2016 | - | $3.86 M(+14.4%) |
| Jun 2016 | - | $3.38 M(-12.1%) |
| Mar 2016 | - | $3.84 M(+50.7%) |
| Dec 2015 | $2.55 M(+141.0%) | $2.55 M(+4.0%) |
| Sep 2015 | - | $2.45 M(-10.5%) |
| Jun 2015 | - | $2.74 M(+122.6%) |
| Mar 2015 | - | $1.23 M(+16.3%) |
| Dec 2014 | $1.06 M(-25.1%) | $1.06 M |
| Dec 2013 | $1.41 M | - |
FAQ
- What is Spyre Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics annual total liabilities year-on-year change?
- What is Spyre Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly total liabilities year-on-year change?
What is Spyre Therapeutics annual total liabilities?
The current annual total liabilities of SYRE is $90.68 M
What is the all time high annual total liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high annual total liabilities is $157.84 M
What is Spyre Therapeutics annual total liabilities year-on-year change?
Over the past year, SYRE annual total liabilities has changed by -$67.16 M (-42.55%)
What is Spyre Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SYRE is $90.68 M
What is the all time high quarterly total liabilities for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly total liabilities is $452.67 M
What is Spyre Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SYRE quarterly total liabilities has changed by -$67.16 M (-42.55%)